Abstract
We report the case of an eradicated multiresistant Serratia marcescens prosthetic hip joint infection. It is estimated that enteric Gram-negative organisms account for approximately 8% of prosthetic joint infections. However, the evolving multiresistant strains of organisms being encountered in hospital acquired infections is making eradication increasingly difficult. We describe n our surgical and microbiological approach to this in a complex case.
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use*
-
Arthroplasty, Replacement, Hip / adverse effects
-
Ciprofloxacin / pharmacology
-
Ciprofloxacin / therapeutic use*
-
Gentamicins / pharmacology
-
Gentamicins / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Prosthesis-Related Infections / drug therapy*
-
Prosthesis-Related Infections / microbiology*
-
Serratia Infections / drug therapy*
-
Serratia Infections / microbiology
-
Serratia marcescens / drug effects*
-
Serratia marcescens / isolation & purification*
Substances
-
Anti-Bacterial Agents
-
Gentamicins
-
Ciprofloxacin